Moderna, Inc. (MRNA) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals a 69% revenue decline and a significant drop in net income, indicating financial stress. Increased R&D expenses and reduced cash reserves further highlight financial strain. The lack of strategic updates or risk management discussion adds to uncertainty, suggesting a strong negative sentiment.
Key Financial Performance
Revenue $1.86 billion, a decrease of 69% year-over-year, primarily due to lower demand for COVID-19 vaccines as the pandemic wanes.
Research and Development (R&D) Expenses $1.1 billion, an increase of 25% year-over-year, driven by investments in pipeline development and clinical trials for new vaccines and therapeutics.
Net Income $79 million, a significant decrease from $3.66 billion year-over-year, attributed to reduced vaccine sales and increased R&D spending.
Cash and Cash Equivalents $14.6 billion, a decrease from $17.3 billion year-over-year, reflecting ongoing investments in research and infrastructure.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Alexandria Hammond
Baker Rothschild
Bank
Bernstein Institutional
Breen Bernstein
Chase Co
Citigroup Inc
Co Redburn
Co Research
Cory Kasimov
Courtney Breen
Director Mock
Division Alexandria
Division Cory
Division Courtney
Division Fye
Division Geoffrey
Division Lin
Division Simon
Division Terence
Division Tyler
Division Yee
EDT day
Eliana Merle
Flynn Morgan
Fye JPMorgan
Geoffrey Meacham
Hammond Wolfe
IR conference
Inc Research
JPMorgan Chase
LLC EDT
LLC Research
Research Division
MRNA Transcript
Moderna, Inc. (MRNA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Neutral6-9
Moderna, Inc. (MRNA) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Neutral5-30
Moderna, Inc. (MRNA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Neutral5-19
Moderna, Inc. (MRNA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Neutral5-12
MRNA Slides
MRNA Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
